Zobrazeno 1 - 6
of 6
pro vyhledávání: '"SANTIAGO AGUIN"'
Autor:
SANTIAGO AGUIN, ALBERTO CARRAL, LETICIA IGLESIAS, CAROLINA PENA, AUREA MOLINA, MARINHA COSTA, MARTA COVELA, JESUS GARCIA GOMEZ, RAMÓN GARCIA ARROYO, GERARDO HUIDOBRO, ROCÍO VILCHES SIMO, ANA MEDINA
Publikováno v:
Cancer Diagn Progn
Background/Aim: Prior immune-checkpoint inhibitors, weekly paclitaxel-cetuximab was one of the few options for platinum-ineligible patients with recurrent/ metastatic squamous cell carcinoma of the head and neck (R/M-SCCHN). This real-world study ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ca9e65dce1e059f18c814a6b5719ef
https://europepmc.org/articles/PMC9949534/
https://europepmc.org/articles/PMC9949534/
Autor:
Patricia Mondelo‐Macía, Jorge García‐González, Luis León‐Mateos, Urbano Anido, Santiago Aguín, Ihab Abdulkader, María Sánchez‐Ares, Alicia Abalo, Aitor Rodríguez‐Casanova, Ángel Díaz‐Lagares, Ramón Manuel Lago‐Lestón, Laura Muinelo‐Romay, Rafael López‐López, Roberto Díaz‐Peña
Publikováno v:
Molecular Oncology, Vol 15, Iss 11, Pp 2923-2940 (2021)
Immune checkpoint inhibitors, such as pembrolizumab, are revolutionizing therapeutic strategies for different cancer types, including non‐small‐cell lung cancer (NSCLC). However, only a subset of patients benefits from this therapy, and new bioma
Externí odkaz:
https://doaj.org/article/7dcbf8034e23478fb0df2c8c6b390edf
Autor:
Alexandra Sabela Cortegoso mosquera, Sonia Candamio Folgar, Rafael López, Luis Leon Mateos, Maria Vieito, C. Lopez, Urbano Anido Herranz, Marta Carmona Campos, Elena Brozos Vazquez, Rafael Varela Ponte, Santiago Aguin Losada, Nieves Martinez Lago
Publikováno v:
Journal of Clinical Oncology. 31:e16095-e16095
e16095 Background: CRPC remains a therapeutic challenge, although in recent years the introduction of new agents has allowed an improvement in overall survival of these patients. In the literature there are few data on the use of cyclophosphamide in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b22cf937ec392617b1d8018b7c43f4fd
https://doi.org/10.1200/jco.2013.31.15_suppl.e16095
https://doi.org/10.1200/jco.2013.31.15_suppl.e16095
Autor:
Santiago Aguin Losada, Yolanda Vidal, Francisco Baron, Maria Vieito, Marta Carmona Campos, Sonia Candamio, Rafael Varela Ponte, Nieves Martinez Lago, Rafael López, Luis León, C. Lopez, Urbano Anido
Publikováno v:
Journal of Clinical Oncology. 30:e19505-e19505
e19505 Background: Although its mortality has decreased in the last years, neutropenic fever is still one of the most important oncological emergencies. Methods: We have assessed the epidemiological data on patients admitted or evaluated for neutrope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4643282c34a9e516d75e7c956949f336
https://doi.org/10.1200/jco.2012.30.15_suppl.e19505
https://doi.org/10.1200/jco.2012.30.15_suppl.e19505
Autor:
Elena Brozos Vazquez, Rafael López, C. Lopez, Urbano Anido, Yolanda Vidal, Nieves Martinez Lago, Maria Vieito, Elena Gallardo, Juan Fernando Cueva Bañuelos, Rafael Varela Ponte, Marta Carmona Campos, Santiago Aguin Losada, Sonia Candamio, Francisca Vazquez
Publikováno v:
Journal of Clinical Oncology. 30:e14733-e14733
e14733 Background: Biliary tract tumours are rare and often poor prognosis cancers that comprise cholangiocarcinomas, ampullary tumours and gallbladder cancers. Methods: Medical Electronic Records for patients diagnosed between January 2008 and Decem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50da15f03e2e74d24524828b0e11fdc1
https://doi.org/10.1200/jco.2012.30.15_suppl.e14733
https://doi.org/10.1200/jco.2012.30.15_suppl.e14733
Autor:
Patricia Mondelo-Macía, Carmela Rodríguez-López, Laura Valiña, Santiago Aguín, Luis León-Mateos, Jorge García-González, Alicia Abalo, Oscar Rapado-González, Mercedes Suárez-Cunqueiro, Angel Díaz-Lagares, Teresa Curiel, Silvia Calabuig-Fariñas, Aitor Azkárate, Antònia Obrador-Hevia, Ihab Abdulkader, Laura Muinelo-Romay, Roberto Diaz-Peña, Rafael López-López
Publikováno v:
Cells, Vol 9, Iss 2, p 522 (2020)
MET alterations may provide a potential biomarker to evaluate patients who will benefit from treatment with MET inhibitors. Therefore, the purpose of the present study is to investigate the utility of a liquid biopsy-based strategy to assess MET alte
Externí odkaz:
https://doaj.org/article/8a077cddf3f24975be87c0ac39fd7b8c